Mental Health News and Research

Latest Mental Health News and Research

LKSOM and Hunter jointly receive $13.5 million grant from National Cancer Institute

The Lewis Katz School of Medicine at Temple University and Hunter College of the City University of New York have jointly received a five-year, $13.5 million grant from the National Cancer Institute.

30 Oct 2018

Scientists find new approach to assess risks of overall health collapse in humans

Medical diagnoses mostly focuses on resolving isolated issues. But, fixing one problem may create others and even invoke an overall health collapse. Scientists now found a new approach to assess the risks of such collapse in humans and other animals using data from wearable sensors.

30 Oct 2018

Higher screen time linked to increased levels of anxiety in children, finds study

Too much time spent on gaming, smartphones and watching television is linked to heightened levels and diagnoses of anxiety or depression in children as young as age 2, according to a new study.

30 Oct 2018

Atopic dermatitis found to be highly prevalent among adults in the U.S.

As many as 16.5 million adults in America suffer from a skin disease known as atopic dermatitis, an inflammatory disease that results in red, itchy skin.

30 Oct 2018

UTHealth's Valentin Dragoi wins $1.6 million NIH award to unlock mysteries of the brain

Working to further the understanding of how the brain processes information, Valentin Dragoi, Ph.D., of The University of Texas Health Science Center at Houston has been awarded a three-year, $1.6 million award from the National Institutes of Health's Brain Research through Advancing Innovative Neurotechnologies Initiative.

30 Oct 2018

Exercise could reduce risk of falling for older adults with AD

Alzheimer's disease is a brain disease that causes changes that kill brain cells. AD is a type of dementia, which causes memory loss and problems with thinking and making decisions.

29 Oct 2018

Investigational drug targeting the opioid system may help reduce symptoms of major depression

Two clinical trials of an investigational drug that targets the opioid system support its safety and effectiveness in reducing symptoms of major depression, when added to standard antidepressant treatment.

29 Oct 2018

Researchers receive grant to study treatment options for binge eating disorder in veterans

For the first time, the United States Department of Defense has awarded a grant to researchers at University of California San Diego School of Medicine to study binge eating disorder treatments in veterans and active duty military.

29 Oct 2018

Releasing Control from Practitioner to Patient Through Technology

An interview with Sarah Fairburn, discussing the NHS and how LumiraDx were able to change the model of care for anticoagulants through the engage app.

From LumiraDx Limited 29 Oct 2018

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced study results on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia experiencing severe psychotic symptoms during an acute episode. The data will be presented at the upcoming Psych Congress, held in Orlando from October 25-28, 2018.

26 Oct 2018

High-impact clinical trial results could affect kidney-related medical care

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2018 October 23-October 28 at the San Diego Convention Center.

26 Oct 2018

New discovery may unlock development of next-generation sleeping pill

Insomnia is one of the major sleep problems with an estimated prevalence of 10% to 15% in the general population and 30% to 60% in the older population. Moreover, insomnia frequently co-occurs with a wide range of psychiatric disorders, including depression and anorexia.

26 Oct 2018

Innovative supportive care model tackles burdensome symptoms, challenges of dementia

Individuals with dementia often experience burdensome symptoms such as agitation, aggression, anxiety and pain, but have difficulty with comprehension and communication, making it challenging for healthcare providers to provide appropriate treatment.

26 Oct 2018

Active ingredient in magic mushrooms could soon become a depression treatment

The active ingredient in magic mushrooms is psilocybin. Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushroom and is the reason behind the “high” provided by the magic mushrooms. Now, Psilocybin may soon achieve legal status to be used for treatment of difficult to treat depressive illness.

26 Oct 2018

UTA social work professors use NIH grant to find ways for reducing caregiver stress

Two UTA social work professors are using an NIH grant to find ways to reduce stress of families caring for loved ones with Alzheimer's disease.

26 Oct 2018

Good mental ability and grip strength may prevent or delay disability in older adults

As we age, we may develop certain disabilities that make it difficult to walk, climb, balance, or maintain our fine motor skills.

25 Oct 2018

Kent State professor receives NIH grant to study neurological roots of fear memories

People who suffer trauma will, with few exceptions, never forget what happened to them, but a Kent State University researcher may be able to offer them the hope of living without constant fear and anxiety.

25 Oct 2018

Tooth loss linked to malnutrition risk in older adults

Older adults are at risk for both impaired oral health and malnutrition, according to a study by Rutgers University researchers.

25 Oct 2018

Head and neck cancer survivors more likely to commit suicide

Despite improved survival rates among cancer patients, the risk of death by suicide remains high, especially among those treated for head and neck cancers.

25 Oct 2018

APA calls on federal government to fund physiotherapy as first line treatment for osteoarthritis

Osteoarthritis is a debilitating and painful condition affecting more than 2.2 million Australians at a cost to the health system of $2.1 billion annually. As Australia’s population ages and obesity rates climb, this figure is expected to grow to more than 3 million by 2030.

25 Oct 2018

Mental Health News and Research

Latest Mental Health News and Research

LKSOM and Hunter jointly receive $13.5 million grant from National Cancer Institute

Scientists find new approach to assess risks of overall health collapse in humans

Higher screen time linked to increased levels of anxiety in children, finds study

Atopic dermatitis found to be highly prevalent among adults in the U.S.

UTHealth's Valentin Dragoi wins $1.6 million NIH award to unlock mysteries of the brain

Exercise could reduce risk of falling for older adults with AD

Investigational drug targeting the opioid system may help reduce symptoms of major depression

Researchers receive grant to study treatment options for binge eating disorder in veterans

Releasing Control from Practitioner to Patient Through Technology

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

High-impact clinical trial results could affect kidney-related medical care

New discovery may unlock development of next-generation sleeping pill

Innovative supportive care model tackles burdensome symptoms, challenges of dementia

Active ingredient in magic mushrooms could soon become a depression treatment

UTA social work professors use NIH grant to find ways for reducing caregiver stress

Good mental ability and grip strength may prevent or delay disability in older adults

Kent State professor receives NIH grant to study neurological roots of fear memories

Tooth loss linked to malnutrition risk in older adults

Head and neck cancer survivors more likely to commit suicide

APA calls on federal government to fund physiotherapy as first line treatment for osteoarthritis

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Mental Health News and Research

Latest Mental Health News and Research

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in